Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy

Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, Hautmann M, Brunner T, Tamaskovics B, Hinke A, Zhou J, Frey B, Donaubauer AJ, Becker I, Semrau S, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Gostian AO, Fietkau R (2022)


Publication Language: English

Publication Type: Conference contribution, Abstract of a poster

Publication year: 2022

Journal

Publisher: KARGER

Series: Oncology Research and Treatment

City/Town: BASEL

Book Volume: 45 (Suppl. 3)

Pages Range: 130

Event location: Berlin DE

DOI: 10.1159/000521004

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hecht, M., Eckstein, M., Kallies, A., von der Grün, J., Illmer, T., Klautke, G.,... Fietkau, R. (2022, November). Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy. Poster presentation at 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, Berlin, DE.

MLA:

Hecht, Markus, et al. "Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy." Presented at 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, Berlin BASEL: KARGER, 2022.

BibTeX: Download